CVS Health Co. (NYSE:CVS) Holdings Lowered by Clarius Group LLC

Clarius Group LLC lessened its stake in shares of CVS Health Co. (NYSE:CVS) by 7.6% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 8,757 shares of the pharmacy operator’s stock after selling 721 shares during the period. Clarius Group LLC’s holdings in CVS Health were worth $517,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the company. Bourgeon Capital Management LLC raised its holdings in shares of CVS Health by 8.2% during the second quarter. Bourgeon Capital Management LLC now owns 129,002 shares of the pharmacy operator’s stock valued at $7,619,000 after acquiring an additional 9,737 shares during the period. CX Institutional grew its holdings in shares of CVS Health by 38.3% during the second quarter. CX Institutional now owns 9,350 shares of the pharmacy operator’s stock valued at $552,000 after buying an additional 2,589 shares in the last quarter. Warther Private Wealth LLC boosted its position in CVS Health by 28.7% during the 2nd quarter. Warther Private Wealth LLC now owns 153,369 shares of the pharmacy operator’s stock worth $9,058,000 after acquiring an additional 34,207 shares during the period. Olstein Capital Management L.P. increased its holdings in shares of CVS Health by 20.2% in the 2nd quarter. Olstein Capital Management L.P. now owns 155,000 shares of the pharmacy operator’s stock valued at $9,154,000 after purchasing an additional 26,000 shares during the period. Finally, Greenfield Savings Bank lifted its position in shares of CVS Health by 7.2% in the second quarter. Greenfield Savings Bank now owns 21,263 shares of the pharmacy operator’s stock worth $1,256,000 after purchasing an additional 1,420 shares in the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on CVS. UBS Group lowered shares of CVS Health from a “buy” rating to a “neutral” rating and decreased their target price for the company from $85.00 to $60.00 in a research note on Thursday, May 2nd. Baird R W raised CVS Health to a “hold” rating in a research note on Thursday, May 30th. Truist Financial reaffirmed a “buy” rating and set a $66.00 price objective (down previously from $90.00) on shares of CVS Health in a research report on Thursday, May 2nd. Cantor Fitzgerald lifted their target price on shares of CVS Health from $58.00 to $62.00 and gave the company a “neutral” rating in a research note on Thursday. Finally, Leerink Partnrs lowered shares of CVS Health from an “outperform” rating to a “market perform” rating in a research note on Wednesday, May 1st. Eleven analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $73.70.

CVS Health Trading Down 1.1 %

Shares of CVS stock traded down $0.64 on Friday, reaching $57.21. The company had a trading volume of 1,449,787 shares, compared to its average volume of 11,501,835. The stock has a market cap of $71.82 billion, a PE ratio of 10.17, a PEG ratio of 0.57 and a beta of 0.52. The company has a 50-day moving average of $59.50 and a 200-day moving average of $66.37. The company has a current ratio of 0.81, a quick ratio of 0.61 and a debt-to-equity ratio of 0.78. CVS Health Co. has a 12 month low of $52.77 and a 12 month high of $83.25.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, beating the consensus estimate of $1.74 by $0.09. The business had revenue of $91.23 billion for the quarter, compared to analysts’ expectations of $91.41 billion. CVS Health had a return on equity of 13.53% and a net margin of 2.03%. CVS Health’s revenue for the quarter was up 2.6% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.21 EPS. On average, equities analysts forecast that CVS Health Co. will post 7 earnings per share for the current year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, August 1st. Shareholders of record on Monday, July 22nd were paid a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.65%. The ex-dividend date of this dividend was Monday, July 22nd. CVS Health’s dividend payout ratio is 46.75%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.